SIGLEC9 and melanoma: We have also demonstrated that the trans interaction between DSG2 on A375 melanoma cells and Siglec‐9 on macrophages has a significant impact on the Siglec‐9‐mediated immunosuppressive signaling and knocking down DSG2 releases immunosuppression and increases phagocytosis.